Dis-Chem Pharmacies Ltd
JSE:DCP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Country Average (21.1), the stock would be worth Zac-1 709.4 (147% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -45.1 | Zac3 650 |
0%
|
| Country Average | 21.1 | Zac-1 709.4 |
-147%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
31.3B ZAR | -45.1 | 25.3 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
62B ZAR | 61.2 | 19.2 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD | -10.3 | -1.6 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
37.5B BRL | 180 | 29.5 | |
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
932.2B JPY | 4.5 | 22 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
909.7B JPY | 23.8 | 16.5 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 136.7 | 20.2 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
28.1B CNY | 9.3 | 16.3 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 24.5 | 34.3 | |
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
566.4B JPY | 5.1 | 12.5 | |
| CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
21.3B CNY | 7.7 | 16.6 |
Market Distribution
| Min | 11.2 |
| 30th Percentile | 21.1 |
| Median | 21.1 |
| 70th Percentile | 22.7 |
| Max | 26.3 |
Other Multiples
Dis-Chem Pharmacies Ltd
Glance View
Dis-Chem Pharmacies Ltd., a notable player in South Africa's pharmaceutical landscape, has navigated a path of consistent growth since its inception in 1978. Founded by Ivan and Lynette Saltzman, the company emerged as a disruptor in the pharmacy retail sector by fusing exceptional customer service with an expansive range of wellness products. The Saltzmans began with a single pharmacy in Mondeor, Gauteng, but their vision quickly materialized into a nation-spanning network of outlets. Today, Dis-Chem stands as one of the country's leading pharmacy groups, offering a broad spectrum of healthcare and personal care products, grouped conveniently under one roof to appeal to a growing health-conscious consumer base. At the core of Dis-Chem's business model is its value proposition of offering a diversified array of products that ranges from prescription medication to cosmetics and nutraceuticals. Unlike standard pharmacies, Dis-Chem operates a strategic retail footprint that not only sells health services and products but also engages in wholesale distribution through its integrated warehouse facilities. This vertically integrated approach allows Dis-Chem to maintain competitive pricing while optimizing supply chain efficiencies. The company, thereby, successfully generates revenue through both direct consumer sales and wholesale distribution to independent pharmacies, driving consistent profitability and reinforcing its standing as a trusted healthcare provider to the South African populace.